SCHEMBL3467645

SCHEMBL3467645

COC(=O)C(CCCc1ccccc1)CCc1ccc(-c2cccc(C(F)(F)F)c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 4/20 0.56
MMP3 P08254 4/20 0.56
SLC13A5 Q86YT5 1/20 0.48
GPR34 Q9UPC5 1/20 0.47
KIFC1 Q9BW19 1/20 0.46
MAOB P27338 1/20 0.46
S1PR5 Q9H228 1/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2C19 P33261 2/20 0.46
TP53 P04637 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
TSHR P16473 1/20 0.46
SIGMAR1 Q99720 1/20 0.46
MGLL Q99685 1/20 0.45
MME P08473 1/20 0.45
HDAC1 Q13547 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
BACE1 P56817 1/20 0.43
CDK2 P24941 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3466524 0.90 FDFT1 (0.51) MMP2MMP3MGLLHDAC1HDAC8
SCHEMBL3467260 0.88 MMP2 (0.60) MMP2MMP3SLC13A5GPR34KIFC1
SCHEMBL1860059 0.87 MMP12 (0.53) MMP2MMP3MMEHDAC1
SCHEMBL3466739 0.86 MMP2 (0.52) MMP2MMP3GPR34MGLLMME
SCHEMBL3468279 0.85 HCAR2 (0.47) MMEHDAC1PDE4D
SCHEMBL3466501 0.84 HCAR2 (0.52) MMP3SLC13A5MAOBMME
SCHEMBL3467101 0.83 FOLH1 (0.46) MGLLMMEPDE4D
SCHEMBL3466571 0.82 MMP2 (0.48) MMP2MMP3MME
SCHEMBL3467349 0.82 PDE4A (0.53) PDE4D
SCHEMBL1857332 0.82 LTA4H (0.52) MMP2MMP3PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO claimed
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO disclosed